DAPAGLIFLOZIN for Type 2 diabetes mellitus: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5,444 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN was used for Type 2 diabetes mellitus.
Most Reported Side Effects for DAPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,775 | 13.0% | 2,774 | 52 |
| Diabetic ketoacidosis | 1,773 | 8.3% | 61 | 1,154 |
| Acute kidney injury | 982 | 4.6% | 67 | 768 |
| Off label use | 891 | 4.2% | 28 | 310 |
| Nausea | 884 | 4.1% | 20 | 363 |
| Dehydration | 860 | 4.0% | 67 | 451 |
| Vomiting | 838 | 3.9% | 27 | 419 |
| Dizziness | 817 | 3.8% | 30 | 293 |
| Ketoacidosis | 803 | 3.8% | 30 | 471 |
| Fatigue | 785 | 3.7% | 8 | 227 |
| Diarrhoea | 769 | 3.6% | 32 | 317 |
| Dyspnoea | 760 | 3.6% | 21 | 328 |
| Malaise | 737 | 3.5% | 30 | 308 |
| Weight decreased | 727 | 3.4% | 23 | 231 |
| Blood glucose increased | 699 | 3.3% | 12 | 247 |
Other Indications for DAPAGLIFLOZIN
Diabetes mellitus (3,347)
Product used for unknown indication (1,534)
Cardiac failure (1,332)
Chronic kidney disease (585)
Ill-defined disorder (556)
Cardiac failure chronic (498)
Type 1 diabetes mellitus (308)
Blood glucose increased (145)
Blood glucose abnormal (127)
Blood glucose decreased (72)
Other Drugs Used for Type 2 diabetes mellitus
INSULIN GLARGINE (41,731)
METFORMIN (25,080)
DULAGLUTIDE (24,742)
SEMAGLUTIDE (17,910)
INSULIN LISPRO (16,871)
EXENATIDE (16,403)
TIRZEPATIDE (14,571)
EMPAGLIFLOZIN (12,176)
CANAGLIFLOZIN (10,795)
PIOGLITAZONE (8,418)